Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Update on therapeutic monoclonal antibodies.

Bussel JB, Giulino L, Lee S, Patel VL, Sandborg C, Stiehm ER.

Curr Probl Pediatr Adolesc Health Care. 2007 Apr;37(4):118-35. Review.

PMID:
17434008
2.

[Monoclonal antibodies. Principles, generation, application, and side effects].

Sack U, Emmrich F.

Internist (Berl). 2008 Aug;49(8):919-20, 921-4, 926-8. doi: 10.1007/s00108-008-2055-6. Review. German.

PMID:
18587546
3.

Monoclonal antibody therapy of inflammatory rheumatic diseases.

Breedveld FC, van der Lubbe PA.

Br Med Bull. 1995 Apr;51(2):493-502. Review.

PMID:
7552078
4.

-ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?

Ballow M.

J Allergy Clin Immunol. 2005 Oct;116(4):738-43. Review. No abstract available.

PMID:
16210044
5.

Monoclonal antibody-based strategies in autoimmunity and transplantation.

Chatenoud L.

Methods Mol Med. 2005;109:297-328. Review.

PMID:
15585929
6.

[Monoclonal antibodies and therapeutics].

Desgranges C.

Pathol Biol (Paris). 2004 Jul;52(6):351-64. Review. French.

PMID:
15261379
7.

Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions.

Cavagna L, Saketkoo LA, Schwarting A, Caporali R.

Biomed Res Int. 2014;2014:481973. doi: 10.1155/2014/481973. Epub 2014 Aug 10. No abstract available.

8.

B cell depletion in autoimmune rheumatic diseases.

Pitashny M, Shoenfeld Y.

Autoimmun Rev. 2005 Sep;4(7):436-41. Epub 2005 Apr 1. Review.

PMID:
16137609
9.

Trends in the development of therapeutic anti-cytokine antibodies.

Reichert JM.

Drug Discov Today. 2004 Apr 15;9(8):348. No abstract available.

PMID:
15081960
10.

Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?

Kelly KM, Pritchard J.

Br J Cancer Suppl. 1994 Sep;23:S54-5. Review.

11.

Novel therapeutic targets along the Th17 pathway.

Ouyang W, Filvaroff E, Hu Y, Grogan J.

Eur J Immunol. 2009 Mar;39(3):670-5. doi: 10.1002/eji.200839105.

12.

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.

Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Nat Clin Pract Rheumatol. 2007 May;3(5):262-72. Review.

PMID:
17471245
13.

mAbs in nonlupus autoimmune rheumatic disease.

Whelan BR, Isenberg DA.

Curr Opin Hematol. 2009 Jul;16(4):280-4. doi: 10.1097/MOH.0b013e32832c1f53. Review.

PMID:
19444098
14.

Monoclonal antibodies in the immunotherapy of autoimmune diseases.

Perosa F, Luccarelli G, Prete M, Dammacco F.

Ann Ital Med Int. 2001 Oct-Dec;16(4):220-32. Review.

PMID:
11799630
15.

New solid tumor targets for therapeutic monoclonal antibodies.

Papkoff J.

Expert Opin Ther Targets. 2007 May;11(5):585-8.

PMID:
17465718
16.

Approved monoclonal antibodies for cancer therapy.

Boyiadzis M, Foon KA.

Expert Opin Biol Ther. 2008 Aug;8(8):1151-8. doi: 10.1517/14712598.8.8.1151 . Review.

PMID:
18613766
17.

[Biological therapy for the treatment of rheumatic diseases].

Pierer M, Baerwald C.

Internist (Berl). 2008 Aug;49(8):938-46. doi: 10.1007/s00108-008-2059-2. Review. German.

PMID:
18587545
18.

Monoclonal antibodies to tissue-associated antigens as antitumor reagents.

Carroll AM, Zalutsky MR, Benacerraf B, Greene MI.

Surv Synth Pathol Res. 1984;3(3):189-200. Review. No abstract available.

PMID:
6436946
19.

Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

Khawli LA, Hu P, Epstein AL.

Handb Exp Pharmacol. 2008;(181):291-328. Review.

PMID:
18071951
20.

Monoclonal antibodies in rheumatic diseases.

Yuvienco C, Schwartz S.

Med Health R I. 2011 Nov;94(11):320-4. Review. No abstract available.

PMID:
22204094

Supplemental Content

Support Center